IP Verse

A Cell Mediated Immune Response Assay With Enhanced Sensitivity - EP2726883

The patent EP2726883 was granted to Cellestis on May 18, 2022. The application was originally filed on Jun 27, 2012 under application number EP12804281A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2726883

CELLESTIS
Application Number
EP12804281A
Filing Date
Jun 27, 2012
Status
Patent Maintained As Amended
Apr 15, 2022
Publication Date
May 18, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BIOMERIEUXDec 27, 2018CABINET BEAU DE LOMENIEADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2012AU00420
DESCRIPTIONUS4016043
DESCRIPTIONUS4018653
DESCRIPTIONUS4424279
DESCRIPTIONWO2005118629
INTERNATIONAL-SEARCH-REPORTWO2009121845
OPPOSITIONEP1723426
OPPOSITIONUS2004141985
OPPOSITIONWO2009121845
OTHERWO2009121845
OTHERWO2011075773
SEARCHWO2009121845
SEARCHWO2011075773

Non-Patent Literature (NPL) Citations (54) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- BIGGS ET AL., CYTOMETRY, (1999), vol. 36, pages 36 - 45
DESCRIPTION- DANESHVAR ET AL., J. IMMUNOL. METHODS, (1999), vol. 226, no. 1-2, pages 119 - 128
DESCRIPTION- DURIG ET AL., J. RAMAN SPECTROSC., (1993), vol. 24, no. 5, pages 281 - 285
DESCRIPTION- ERIKSSON ET AL., BIOPHYS. J., (1993), vol. 2, page 64
DESCRIPTION- FU ET AL., NATURE BIOTECHNOLOGY, (1999), vol. 17, pages 1109 - 1111
DESCRIPTION- LAKOWICZ ET AL., BIOPHYS. J., (1997), vol. 72, page 567
DESCRIPTION- LEWIS ET AL., DYES PIGM., (1999), vol. 42, no. 2, page 197
DESCRIPTION- MACCALLI ET AL., CLIN. CANCER RES., (2008), vol. 14, no. 22, pages 7292 - 7303
DESCRIPTION- PETKOVIC-DURAN ET AL., BIOTECHNIQUES, (2009), vol. 47, pages 827 - 834
DESCRIPTION- RAHMAN ET AL., J. ORG. CHEM., (1998), vol. 63, page 6196
DESCRIPTION- RAPAPORT ET AL., APPL. PHYS. LETT., (1999), vol. 74, no. 3, pages 329 - 331
DESCRIPTION- TAWA ET AL., MATER. RES. SOC. SYMP. PROC., vol. 488, pages 885 - 890
DESCRIPTION- TULLY ET AL., THE JOURNAL OF IMMUNOLOGY, (2005), vol. 174, pages 2174 - 2184
DESCRIPTION- YOUVAN ET AL., BIOTECHNOLOGY, (1997), vol. 3, pages 1 - 18
INTERNATIONAL-SEARCH-REPORT- TULLY, G. ET AL., "Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection", THE JOURNAL OF IMMUNOLOGY, (2005), vol. 174, no. 4, pages 2174 - 2184, XP002535763
INTERNATIONAL-SEARCH-REPORT- GOLETTI, D. ET AL., "Accuracy of an immune diagnostic assay based on RD selected epitopes for active tuberculosis in a clinical setting: a pilot study", CLINICAL MICROBIOLOGY AND INFECTION, (2006), vol. 12, no. 6, pages 544 - 550, XP055141618
INTERNATIONAL-SEARCH-REPORT- MACCALLI, C. ET AL., "Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1", CLINICAL CANCER RESEARCH, (2008), vol. 14, pages 7292 - 7303, XP055070217
INTERNATIONAL-SEARCH-REPORT- ARIF, S. ET AL., "Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health", THE JOURNAL OF CLINICAL INVESTIGATION, (2004), vol. 113, no. 3, pages 451 - 463, XP055070221
INTERNATIONAL-SEARCH-REPORT- OUYANG, Q. ET AL., "Recognition of HLA Class I-restricted beta-cell epitopes in type I diabetes", DIABETES, (2006), vol. 55, pages 3068 - 3074, XP055070222
INTERNATIONAL-SEARCH-REPORT- CAMARCA, A. ET AL., "Intestinal T cell responses to gluten peptides are largely heterogenous: implications for a peptide-based therapy in celiac disease", THE JOURNAL OF IMMUNOLOGY, (2009), vol. 182, pages 4158 - 4166, XP055070215
OPPOSITION- Allen et al, Tuberculosis, (20180000), vol. 113, pages 239 - 241
OPPOSITION- anonymous, "QuantiFERON® -TB Gold (In-Tube Method) The Whole Blood IFN-gamma Test Measuring Responses to ESAT-6, CFP-10 & TB7.7 Peptide Antigens", Cellestis, (20060800), pages 1 - 33, XP055543205
OPPOSITION- Arend Sandra M et al, Infection and Immunology, (20000600), vol. 68, no. 6, pages 3314 - 3321
OPPOSITION- Chien et al, Journal of Clinical Microbiology, (20180000), vol. 56, no. 8, pages 1 - 12
OPPOSITION- Elvang et al, Plos One, (200904001), vol. 4, no. 4, page e5139
OPPOSITION- Gahery, Hanne et al, AIDS, (20070000), vol. 23, no. 3, pages 427 - 437
OPPOSITION- Kiecker et al, Immunology, (20040000), vol. 65, pages 523 - 536
OPPOSITION- Kim et al, The Korean Journal of Internal Medicine, vol. 20191200
OPPOSITION- Lundegaard et al, Immunology, (20100000), vol. 130, pages 309 - 318
OPPOSITION- Murthy, Madhan Kumar, Journal of Interferon and Cytokine Research, (20110000), vol. 31, no. 3, pages 299 - 307
OPPOSITION- NAN ZHENG et al., "Strong Ability of Nef-Specific CD 4+ Cytotoxic T cells to suppress human immunodeficiency virus Type 1 (HIV-1) replication in HIV-1-Infected CD 4+ T cells and macrophages", Journal of virology, (20090800), vol. 83, no. 15, pages 7668 - 7677, XP055543163
OPPOSITION- Nielson et al, Immunology, (20100000), vol. 130, pages 319 - 328
OPPOSITION- NOELLA D. MOSHI, "Chapter Three: Identification of immunodominant CFP10 and ESAT6-specific CD8 T cell responses in individuals with latent and active TB disease", Characterization of CD 8 T Cell Responses in Mycobacterium tuberculosis infection, (20111115), pages i-viii, 35 - 61, XP055543184
OPPOSITION- THOMAS O. KLEEN et al., "Tc1 effector diversity shows dissociated expression of granzyme B and interferon-Y in HIV infection", AIDS, (20040000), vol. 18, no. 3, pages 383 - 392, XP055543149
OPPOSITION- Vitale Fabrizio et al, Clinical and Vaccine Immunology, (20060400), pages 530 - 533
OPPOSITION- MARIA NIKOLOVA et al., "Antigen-specific CD 4- and CD 8- positive signatures in différent phases of Mycobacterium tuberculosis infection", Diagnostic Microbiology and Infectious Disease, (20130300), vol. 75, pages 277 - 281, XP028976698
OPPOSITION- FELIX KIECKER et al., "Analysis of Antigen-Specific T- Cell Responses With Synthetic Peptides - What Kind of Peptide for Which Purpose?", Human Immunology, (20040500), vol. 65, no. 5, pages 523 - 536, XP002769406
OPPOSITION- AJIT LALVANI et al., "Human cytolytic and interferon y- secreting CD 8+ T lymphocytes specific for Mycobacterium tuberculosis", Proc. Natl. Acad. Sci. USA, (19980100), vol. 95, pages 270 - 275, XP002173899
OPPOSITION- HANNE GAHERY et al., "HLA-DR-Restricted peptides identified in the Nef protein can induce HIV Type 1-Specific IL -2/IFN-y-secreting CD 4+ and CD 4+/ CD 8+ T cells in humans after Lipopeptide Vaccination", AIDS Research and Human Retroviruses, (20070300), vol. 23, no. 3, pages 427 - 437, XP002464780
OPPOSITION- AMITA GUPTA, "Killing activity and rescue function of genome-wide toxin-antitoxin loci of Mycobacterium tuberculosis", FEMS Microbiol Lett, (20090000), vol. 290, no. 1, pages 45 - 53, XP055543191
OPPOSITION- DANIEL E. KAUFMANN et al., "Comprehensive Analysis Of Human Immunodeficiency Virus Type 1-Specific CD 4 Responses Reveals Marked Immunodominance of gag and nef and the Presence of Broadly Recognized Peptides", Journal of Virology, (20040500), vol. 78, no. 9, pages 4463 - 4477, XP055052492
OPPOSITION- DEBORAH A. LEWINSOHN et al., "Immunodominant Tuberculosis CD 8 Antigens Preferentially Restricted by HLA-B", Plos Pathogens, (20070921), vol. 3, no. 9, pages 1240 - 1249, XP055543168
OPPOSITION- DEREK J. HANSON et al., "Advances in the Characterization of the T- Cell Response to Human Herpesvirus-6", Frontiers in Immunology, (20180625), vol. 9, pages 1 - 8, XP055543140
OPPOSITION- SHAMS et al., "Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD 4+ and CD 8+ T cells in the context of Multiple HLA alleles", The journal of Immunology, (20040801), vol. 173, no. 3, pages 1966 - 1977, XP055543174
OTHER- Kiecker et al., "Analysis of antigen-specific T-Cell responses with synthetic peptides - What kind of peptide for which purpose?", HUMAN IMMUNOLOGY, vol. 65, (20040000), pages 523 - 536, XP002769406
OTHER- Draenert et al., "Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses", JOURNAL OF IMMUNOLOGICAL METHODS, vol. 275, (20030000), pages 19 - 29, XP004416748
OTHER- Appay et al., "HIV-SPECIFIC CD8+ T CELLS PRODUCE ANTIVIRAL CYTOKINES BUT ARE IMPAIRED IN CYTOLYTIC FUNCTION", The Journal of Experimental Medicine, vol. 192, no. 1, (20000703), pages 63 - 75, XP001100698
OTHER- Christian Münz, "Microreview - Autophagy and antigen presentation", Cellular Microbiology, vol. 8, no. 6, (20060000), pages 891 - 898, XP055391366
SEARCH- Cristina Maccalli ET AL, "Induction of both CD8+ and CD4+ T-cell-mediated responses in colorectal cancer patients by colon antigen-1. - Supplementary data-", Clin Cancer Res, 2008, vol. 14, (20081115), pages 7292 - 7303, URL: http://clincancerres.aacrjournals.org/content/suppl/2008/11/14/1078-0432.CCR-08-0832.DC1/Supplementary_Data.pdf, (20150108), XP055160487 [X] 1,2,6,7,10,12,13 * the whole document *
SEARCH- TULLY GLENN ET AL, "Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, (20050215), vol. 174, no. 4, ISSN 0022-1767, pages 2174 - 2184, XP002535763 [X] 1-3,6-8,13 * abstract * * page 2175, paragraphs 3,4; figures 4,5 * [Y] 8
SEARCH- D. GOLETTI ET AL, "Accuracy of an immune diagnostic assay based on RD1 selected epitopes for active tuberculosis in a clinical setting: a pilot study", CLINICAL MICROBIOLOGY AND INFECTION, (20060601), vol. 12, no. 6, doi:10.1111/j.1469-0691.2006.01391.x, ISSN 1198-743X, pages 544 - 550, XP055141618 [X] 1,2,6-8,12,13 * abstract * * page 3, paragraph 1; figure 1; tables 1,3 *
SEARCH- CARL O DEETZ ET AL, "Gamma interferon secretion by human Vgamma2Vdelta2 T cells after stimulation with antibody against the T-cell receptor plus the toll-like receptor 2 agonist Pam3Cys", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, (20060801), vol. 74, no. 8, doi:10.1128/IAI.00088-06, ISSN 0019-9567, pages 4505 - 4511, XP008163486 [X] 1,2,4-7 * abstract * * page 4506, column 1, paragraph 2 *
SEARCH- C. MACCALLI ET AL, "Induction of Both CD8+ and CD4+ T-Cell-Mediated Responses in Colorectal Cancer Patients by Colon Antigen-1", CLINICAL CANCER RESEARCH, (20081115), vol. 14, no. 22, doi:10.1158/1078-0432.CCR-08-0832, ISSN 1078-0432, pages 7292 - 7303, XP055070217 [X] 1-3,6,7,10,12,13 * abstract * * page 7293, column 2 - page 7294, column 2; figures 1,2,4 * * page 7300, column 2 * [Y] 8,9,11 [I] 4,5
SEARCH- A. CAMARCA ET AL, "Intestinal T Cell Responses to Gluten Peptides Are Largely Heterogeneous: Implications for a Peptide-Based Therapy in Celiac Disease", THE JOURNAL OF IMMUNOLOGY, (20090401), vol. 182, no. 7, doi:10.4049/jimmunol.0803181, ISSN 0022-1767, pages 4158 - 4166, XP055070215 [X] 1,2,6,7,9,11,13 * abstract * * page 4160, paragraph 2; figures 1,2,5,6; table 1 * [Y] 9,11

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents